Clinical Trial Update: A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of bemcentinib combined with standard chemoimmunotherapy in untreated advanced/metastatic non-small cell lung cancer with STK11 mutation was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bemcentinib (bemcentinib)

Snippet

Sponsor: BerGenBio ASA | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-10-29